1. From the Department of Urology, Program in Urologic Oncology, Urology Outcomes Research Group and UCSF/Mount Zion Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California (TMD, NS, DJP, GDG, CJK, PRC, DPL), and TAP Pharmaceutical Products Inc., Lake Forest, Illinois (SSM)